Abstract
AbstractHuman papillomaviruses are common sexually transmitted infections, caused by a large diversity of genotypes. In the context of vaccination against a subgroup of genotypes, better understanding the role of genotype interactions and human sexual behavior on genotype ecology is essential. Herein, we present an individual-based model that integrates realistic heterosexual partnership behaviors and simulates interactions between vaccine and non-vaccine genotypes. Genotype interactions were considered, assuming a previous vaccine-genotype infection shortened (competition) or extended (synergy) the duration of a secondary non-vaccine-genotype infection. Sexual behavior determined papillomavirus acquisition and transmission: only 19.5% of active individuals with 0–1 partner during the year, but >80% of those with ≥2 partners, were infected before vaccine introduction. Genotype interactions, despite being silent during the pre-vaccination era, markedly impacted genotype ecology after vaccination started, with a significant increase/decrease of non-vaccine prevalence for competitive/synergistic interactions. These changes were more pronounced in individuals with ≤3 partners (up to 30% of prevalence modification assuming 65% vaccine coverage) but barely visible for individuals with >3 partners (at most 0.30%). Results suggest that considering genotype interactions, in conjunction with heterogeneous sexual behaviors, is essential to anticipate the impact of existing and future anti-papillomavirus vaccines targeting a subgroup of genotypes.
Publisher
Cold Spring Harbor Laboratory
Reference48 articles.
1. A New Tool for Epidemiology: The Usefulness of Dynamic-Agent Models in Understanding Place Effects on Health
2. Bajos, N. , Bozon, M. , 2008. Sexualité, genre et santé?: les apports de l’enquête «Contexte de la sexualité en France?», Enquête sur la sexualité en France. La Découverte.
3. Biryukov, J. , Meyers, C. , 2018. Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection. J. Virol. 92. https://doi.org/10.1128/JVI.01993-17
4. Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings
5. Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease